Thrivent Financial for Lutherans’s Tema Oncology ETF CANC Stock Holding History

Thrivent Financial for Lutherans’s Portfolio CANC Stock Details CANC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.67M	Buy	186,062 +40,111	+27%	+$1.52M	0.01%	786
2026 Q1	$5.36M	Sell	145,951 -1,315,698	-90%	-$47.9M	0.01%	879
2025 Q4	$50.7M	Buy	1,461,649 +1,314,177	+891%	+$42.9M	0.09%	271
2025 Q3	$4.23M	Sell	147,472 -810,003	-85%	-$21.5M	0.01%	913
2025 Q2	$23.7M	Buy	957,475 +831,281	+659%	+$20M	0.05%	341
2025 Q1	$3.64M	Sell	126,194 -391,643	-76%	-$9.85M	0.01%	954
2024 Q4	$13.2M	Buy	517,837 +118,328	+30%	+$3.21M	0.03%	576
2024 Q3	$11.4M	Buy	399,509 +80,133	+25%	+$2.31M	0.02%	637
2024 Q2	$8.62M	Buy	+319,376	New	+$8.61M	0.02%	703

Other funds holding CANC

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

PIA

Perennial Investment Advisors Los Angeles, California $1.51B AUM 28.71% 1-Year Est. Return

OIM

Oder Investment Management Woodland Hills, California $149M AUM 20.29% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

WWM

WJ Wealth Management Glendale, Arizona $253M AUM 28.6% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Roxbury Financial Mount Arlington, New Jersey $126M AUM 23.88% 1-Year Est. Return

Thrivent Financial for Lutherans's CANC Position: Q2 2026 in Review

Thrivent Financial for Lutherans increased its Tema Oncology ETF (CANC) stake by 27% in Q2 2026, buying an estimated $1.52M and bringing the position to 186,062 shares worth $7.67M. The position accounts for 0.01% of the portfolio, ranked #786.

Thrivent Financial for Lutherans first reported a position in CANC in Q2 2024 and has held it in 9 quarters since. The position peaked at $50.7M in Q4 2025. 15 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

Thrivent Financial for Lutherans held 186,062 shares of Tema Oncology ETF worth $7.67M as of Q2 2026.
Thrivent Financial for Lutherans bought 40,111 Tema Oncology ETF shares in Q2 2026, an estimated $1.52M.
Tema Oncology ETF made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #786 holding.
Thrivent Financial for Lutherans first reported a position in Tema Oncology ETF in Q2 2024 and has held it in 9 quarters since.
Thrivent Financial for Lutherans's Tema Oncology ETF position peaked at $50.7M in Q4 2025.
15 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.